ArticleFrontiers in psychiatry2026
Cell type-specific alterations in fatty acid metabolism in neuronal subpopulations of schizophrenia and construction of a diagnostic model.
Article in Frontiers in psychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: This study integrates single-cell and bulk RNA-seq to investigate cell type-specific alterations in fatty acid metabolism-related genes in the dorsolateral prefrontal cortex (DLPFC) of schizophrenia (SCZ) patients and to evaluate their potential as diagnostic biomarkers. Methods: Integrating single-cell sequencing data (9 SCZ patients and 14 controls) and Bulk RNA-seq data (GSE174407, GSE107638), cell subpopulation identification and annotation were performed using Seurat. Key genes were identified by integrating differential gene screening, transcriptional regulatory network construction (SCENIC), pseudotime analysis (Monocle 2), and functional enrichment. A multi-gene diagnostic model was established using LASSO regression. Model performance was validated using ROC curves, nomograms, and immune cell correlation analysis. Finally, an MK-801-induced mouse SCZ model was used to validate the expression of key genes via qPCR. Results: The study found that specific neuronal cell subtypes (e.g., CUX2+ NeuN and OPRM1+ NeuN) were significantly upregulated in SCZ, and the differentially expressed genes (DEGs) in these cells (e.g., Conclusion: This study reveals cell type-specific dysregulation of fatty acid metabolism in SCZ and provides a robust five-gene diagnostic model with translational potential.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.